WEKO3
アイテム
{"_buckets": {"deposit": "3d959b5f-c30f-424f-b69f-c7dbca4bdace"}, "_deposit": {"created_by": 12, "id": "3803", "owners": [12], "pid": {"revision_id": 0, "type": "depid", "value": "3803"}, "status": "published"}, "_oai": {"id": "oai:iwatemed.repo.nii.ac.jp:00003803", "sets": ["27", "80"]}, "author_link": ["11275", "11277", "11273", "11274", "11278", "11276"], "item_10001_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2014-03", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "4", "bibliographicPageEnd": "452", "bibliographicPageStart": "447", "bibliographicVolumeNumber": "29", "bibliographic_titles": [{"bibliographic_title": "臨床消化器内科"}]}]}, "item_10001_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "分岐鎖アミノ酸(branched-chain amino acids;BCAA)製剤の経口投与は肝硬変患者の肝性脳症の治療法として広く認識されているが,近年,BCAAの長期経口投与は低アルブミン血症を改善するとともに合併症(腹水・黄疸・食道静脈瘤の破裂・肝発癌)の発現を阻止し,生存率やQOLを改善させることが明らかになり,栄養治療における医学的妥当性が示されている.さらに,インスリン抵抗性の改善を介した肝発癌抑制効果も報告されてきており,さまざまな薬理学的な作用を併せもつpharmacological nutrientsとしてのBCAAの役割が期待されている.(著者抄録)", "subitem_description_type": "Abstract"}]}, "item_10001_heading_23": {"attribute_name": "見出し", "attribute_value_mlt": [{"subitem_heading_banner_headline": "医学部", "subitem_heading_headline": "内科学(消化)", "subitem_heading_language": "ja"}]}, "item_10001_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0911-601X", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "遠藤, 龍人"}], "nameIdentifiers": [{"nameIdentifier": "11273", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "佐原, 圭"}], "nameIdentifiers": [{"nameIdentifier": "11274", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "遠藤, 啓"}], "nameIdentifiers": [{"nameIdentifier": "11275", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "滝川, 康裕"}], "nameIdentifiers": [{"nameIdentifier": "11276", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "加藤, 章信"}], "nameIdentifiers": [{"nameIdentifier": "11277", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鈴木, 一幸"}], "nameIdentifiers": [{"nameIdentifier": "11278", "nameIdentifierScheme": "WEKO"}]}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "*Branched-Chain Amino Acids(治療的利用)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "インスリン抵抗性(合併症,薬物療法)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "エネルギー代謝", "subitem_subject_scheme": "Other"}, {"subitem_subject": "*肝硬変(薬物療法,合併症,食事療法)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "肝細胞癌(予防,薬物療法)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "基礎代謝", "subitem_subject_scheme": "Other"}, {"subitem_subject": "病的血管新生(合併症,薬物療法)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "代謝性疾患(病因)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "蛋白質-エネルギー栄養障害(病因,薬物療法)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "診療ガイドライン", "subitem_subject_scheme": "Other"}, {"subitem_subject": "低アルブミン血症(病因)", "subitem_subject_scheme": "Other"}, {"subitem_subject": "ヒト", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "【肝硬変-診断と治療の進歩】 肝硬変治療の進歩 分岐鎖アミノ酸製剤による治療効果", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "【肝硬変-診断と治療の進歩】 肝硬変治療の進歩 分岐鎖アミノ酸製剤による治療効果"}]}, "item_type_id": "10001", "owner": "12", "path": ["27", "80"], "permalink_uri": "https://iwatemed.repo.nii.ac.jp/records/3803", "pubdate": {"attribute_name": "公開日", "attribute_value": "2014-12-11"}, "publish_date": "2014-12-11", "publish_status": "0", "recid": "3803", "relation": {}, "relation_version_is_last": true, "title": ["【肝硬変-診断と治療の進歩】 肝硬変治療の進歩 分岐鎖アミノ酸製剤による治療効果"], "weko_shared_id": 12}
【肝硬変-診断と治療の進歩】 肝硬変治療の進歩 分岐鎖アミノ酸製剤による治療効果
https://iwatemed.repo.nii.ac.jp/records/3803
https://iwatemed.repo.nii.ac.jp/records/380368e696c4-6506-454b-8cd9-2423473d200d
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2014-12-11 | |||||
タイトル | ||||||
タイトル | 【肝硬変-診断と治療の進歩】 肝硬変治療の進歩 分岐鎖アミノ酸製剤による治療効果 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
遠藤, 龍人
× 遠藤, 龍人× 佐原, 圭× 遠藤, 啓× 滝川, 康裕× 加藤, 章信× 鈴木, 一幸 |
|||||
書誌情報 |
臨床消化器内科 巻 29, 号 4, p. 447-452, 発行日 2014-03 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0911-601X | |||||
見出し | ||||||
大見出し | 医学部 | |||||
小見出し | 内科学(消化) | |||||
言語 | ja |